Mirae Asset Global Etfs Holdings Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82,519 shares of REGN stock, worth $56.7 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
82,519
Previous 80,807
2.12%
Holding current value
$56.7 Million
Previous $84.9 Million
30.8%
% of portfolio
0.13%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.85 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.32 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.25 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...